Global expansion PepTech has completed a new ton-scale manufacturing plant in Shanghai and is expanding non-GMP services into cosmetic, agricultural, and photographic chemicals, signaling opportunities to cross-sell contract manufacturing, scale-up support, and related fine chemical services to sciences teams globally.

Rich catalog A robust portfolio of 2200 specialty building blocks including heteroaromatic boronic acids and chiral amino acids positions PepTech as a potential supplier for early drug discovery programs, medicinal chemistry collaborations, and library sourcing for lead optimization.

Fast, reliable Strong reputation for problem solving, fast turnaround, and clear client communication, suggesting opportunities to engage in time-sensitive chemistry projects, rapid-response CRO partnerships, and high-touch account management for strategic pharma and biotech customers.

Mid-market focus Revenue currently in the 1–10 million range with a small but globally active client base of over 500 customers, indicating potential to scale with mid-market pharma/biotech accounts through targeted BD campaigns and tiered service offerings.

Digital readiness Adopted modern tech stack and analytics tools (AWS, CloudFront, Cloudflare, Microsoft 365, Node.js) coupled with a new website and catalog launches, implying readiness to leverage digital outreach, e-commerce-like ordering, and targeted account-based marketing to accelerate sales growth.